138 related articles for article (PubMed ID: 3554658)
1. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
Transplantation; 1987 May; 43(5):654-8. PubMed ID: 3554658
[TBL] [Abstract][Full Text] [Related]
2. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
[TBL] [Abstract][Full Text] [Related]
3. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
Prentice HG
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
[TBL] [Abstract][Full Text] [Related]
4. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
5. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
Wade JC; Newton B; Flournoy N; Meyers JD
Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
[TBL] [Abstract][Full Text] [Related]
6. Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.
Rayani SA; Nimmo CJ; Frighetto L; Martinusen SM; Nickoloff DM; Reece DE; Jewesson PJ
Ann Pharmacother; 1994; 28(7-8):852-6. PubMed ID: 7949499
[TBL] [Abstract][Full Text] [Related]
7. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
9. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Nebout T; Mazeron MC; Perol Y
Lancet; 1983 Sep; 2(8352):706-8. PubMed ID: 6136841
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.
Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied N; Fernandez Rañada JM; Mandelli F; Kho P; Kennedy L; Bell AR
Lancet; 1994 Mar; 343(8900):749-53. PubMed ID: 7907729
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir and renal transplantation.
Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
[TBL] [Abstract][Full Text] [Related]
14. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H
Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir prophylaxis of herpes-simplex-virus infections.
Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir prophylaxis in bone marrow transplant recipients.
Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
[TBL] [Abstract][Full Text] [Related]
17. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
18. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
Liesveld JL; Abboud CN; Ifthikharuddin JJ; Lancet JE; Wedow LA; Oliva J; Stamm CG; Nichols D
Biol Blood Marrow Transplant; 2002; 8(12):662-5. PubMed ID: 12523578
[TBL] [Abstract][Full Text] [Related]
19. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
Anderson H; Scarffe JH; Sutton RN; Hickmott E; Brigden D; Burke C
Br J Cancer; 1984 Jul; 50(1):45-9. PubMed ID: 6378236
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
